SORTAC Trademark

Trademark Overview


On Wednesday, June 22, 2022, a trademark application was filed for SORTAC with the United States Patent and Trademark Office. The USPTO has given the SORTAC trademark a serial number of 79349852. The federal status of this trademark filing is REGISTERED as of Tuesday, January 30, 2024. This trademark is owned by Draupnir Bio ApS. The SORTAC trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Biochemical preparations for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; chemical preparations for medical purposes neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; biological preparations for medical purposes for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; chemical reagents for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders,...

Medical apparatus and instruments, namely inhalers, pumps, dispensers; Medical instruments, namely inhalers, pumps, dispensers; diagnostic, examination and monitoring equipment for medical purposes, namely medical strips; all of the aforementioned goods not relating to the field of vascular and/or cardiovascular diseases
sortac

General Information


Serial Number79349852
Word MarkSORTAC
Filing DateWednesday, June 22, 2022
Status700 - REGISTERED
Status DateTuesday, January 30, 2024
Registration Number7292341
Registration DateTuesday, January 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements


Goods and ServicesBiochemical preparations for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; chemical preparations for medical purposes neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; biological preparations for medical purposes for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; chemical reagents for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; medical preparations in the form of tablets, capsules, solutions, powders for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; protein synthesis inhibitors being chemical substances and compounds for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; diagnostic preparations and materials namely medical strips
Goods and ServicesMedical apparatus and instruments, namely inhalers, pumps, dispensers; Medical instruments, namely inhalers, pumps, dispensers; diagnostic, examination and monitoring equipment for medical purposes, namely medical strips; all of the aforementioned goods not relating to the field of vascular and/or cardiovascular diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, September 19, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDraupnir Bio ApS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK

Party NameDraupnir Bio ApS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK

Party NameDraupnir Bio ApS
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressDK

Party NameDraupnir Bio ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Saturday, April 8, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 15, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, September 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 23, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, April 4, 2023ASSIGNED TO EXAMINER
Friday, April 7, 2023NON-FINAL ACTION WRITTEN
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 17, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 5, 2023REFUSAL PROCESSED BY MPU
Tuesday, June 6, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 26, 2023REFUSAL PROCESSED BY IB
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 25, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 13, 2023NOTIFICATION PROCESSED BY IB
Tuesday, January 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 30, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 1, 2024FINAL DISPOSITION PROCESSED
Wednesday, May 1, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 21, 2024FINAL DECISION TRANSACTION PROCESSED BY IB